成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
RD International Technology Co., Limited
Firmenname:
RD International Technology Co., Limited
Telefon:
-
E-Mail:
market@ubiochem.com
Nationalit?t:
China
URL:
www.ruidiresearch.com
Produkte insgesamt:
9266
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
Produktkatalog
CX-6258 hydrochloride hydrate
1353858-99-7
C26H27Cl2N3O4
CX-6258 hydrochloride
1353859-00-3
C26H25Cl2N3O3
Zorifertinib
1626387-80-1
C22H23ClFN5O3
Lifirafenib
1446090-79-4
C25H17F3N4O3
CHZ868
1895895-38-1
C22H19F2N5O2
Lavendustin A
125697-92-9
C21H19NO6
PIM-447 dihydrochloride
1820565-69-2
C24H23F3N4O
JAK3-IN-1
1805787-93-2
C26H30ClN7O2
Ilginatinib maleate
1354799-87-3
C25H24FN7O4
Ilginatinib
1239358-86-1
C21H20FN7
Ilginatinib hydrochloride
1239358-85-0
C21H21ClFN7
Naquotinib mesylate
1448237-05-5
C31H46N8O6S
EGFR-IN-3
1660963-42-7
C29H28F2N6O2
Avitinib maleate
1557268-88-8
C30H30FN7O6
NRC-2694
936446-61-6
C24H26N4O3
PF-06459988
1428774-45-1
C19H22ClN7O3
Neratinib
698387-09-6
C30H29ClN6O3
Tarlox-TKI
2135696-72-7
C19H18BrClN6O
Ruxolitinib (S enantiomer)
941685-37-6
C17H18N6
Lestaurtinib
111358-88-4
C26H21N3O4
Gefitinib hydrochloride
184475-55-6
C22H25Cl2FN4O3
Gefitinib D8
857091-32-8
C22H24ClFN4O3
Lapatinib ditosylate
388082-77-7
C36H34ClFN4O7S2
Mutated EGFR-IN-1
1421372-66-8
C25H31N7O
Osimertinib dimesylate
2070014-82-1
C29H37N7O5S
Niclosamide olamine
Phenasal-ethanolamin
1420-04-8
C15H15Cl2N3O5
Khellin
4,9-Dimethoxy-7-methyl-5H-furo-(3,2-g)(1)benzo-pyran-5-on
82-02-0
C14H12O5
Mutant EGFR inhibitor
1421373-62-7
C27H30ClN7O2
CP-724714
383432-38-0
C27H27N5O3
NVP-BSK805 dihydrochloride
1942919-79-0
C27H29ClF2N6O
Homoharringtonine
26833-87-4
C29H39NO9
NSC 74859
501919-59-1
C16H15NO7S
Icotinib Hydrochloride
1204313-51-8
C22H22ClN3O4
Baricitinib phosphate
1187595-84-1
C16H20N7O6PS
RGB-286638
784210-87-3
C29H37Cl2N7O4
AZD1208
1204144-28-4
C21H21N3O2S
Tyrphostin 23
118409-57-7
C10H6N2O2
Rociletinib hydrobromide
1446700-26-0
C27H29BrF3N7O3
Osimertinib mesylate
1421373-66-1
C29H37N7O5S
AG-825
149092-50-2
C19H15N3O3S2
Cerdulatinib hydrochloride
1369761-01-2
C20H28ClN7O3S
SH-4-54
1456632-40-8
C29H27F5N2O5S
GDC-0339
1428569-85-0
C20H22F3N7OS
Itacitinib adipate
1334302-63-4
C32H33F4N9O5
Tarloxotinib bromide
1636180-98-7
C24H24Br2ClN9O3
Ochromycinone
111540-00-2
C19H14O4
TCS PIM-1 1
491871-58-0
C18H11BrN2O2
CX-6258
1202916-90-2
C26H24ClN3O3
Napabucasin
83280-65-3
C14H8O4
GLPG0634 analog
1206101-20-3
C23H18N6O2
Alantolactone
[3aR-(3aα,5β,8aβ,9aα)]-3a,5,6,7,8,8a,9,9a-Octahydro-5,8a-dimethyl-3-methylennaphtho[2,3-b]furan-2(3H)-on
546-43-0
C15H20O2
Cryptotanshinone
35825-57-1
C19H20O3
Diosgenin
(20R,25R)-Spirost-5-en-3β-ol
512-04-9
C27H42O3
Artesunate
88495-63-0
C19H28O8
Cyasterone
17086-76-9
C29H44O8
Nitidine chloride
13063-04-2
C21H18NO4+
Curculigoside
85643-19-2
C22H26O11
Scutellarin
27740-01-8
C21H18O12
Corylifol A
775351-88-7
C25H26O4
Tephrosin
76-80-2
C23H22O7
Brevilin A
16503-32-5
C20H26O5
β-Hydroxyisovalerylshikonin
7415-78-3
C21H24O7
Astragaloside VI
84687-45-6
C47H78O19
Triacetylresveratrol
42206-94-0
C20H18O6
Hispidulin
1447-88-7
C16H12O6
Mogrol
88930-15-8
C30H52O4
Sulforaphene
592-95-0
C6H9NOS2
Ginsenoside Rk1
494753-69-4
C42H70O12
Arnicolide D
34532-68-8
C19H24O5
Garcinone C
76996-27-5
C23H26O7
Coumermycin A1
4434-05-3
C55H59N5O20
EGFR Protein Tyrosine Kinase Substrate
945830-38-6
C48H73N11O17
Cetuximab
205923-56-4
C107H179N35O36S7
Trastuzumab
180288-69-1
C10H14N6O5
Pertuzumab
380610-27-5
C17H27NO2
ZD-4190
413599-62-9
C19H16BrFN6O2
GNE-495
1449277-10-4
C22H20FN5O2
TBHQ
2-(1,1-Dimethylethyl)-1,4-benzoldiol
1948-33-0
C10H14O2
M2698
1379545-95-5
C21H19ClF3N5O
RAF709
1628838-42-5
C28H29F3N4O4
Oclacitinib maleate
1640292-55-2
C19H27N5O6S
(Rac)-JBJ-04-125-02
2140807-05-0
C29H26FN5O3S
Mobocertinib
1847461-43-1
C32H39N7O4
Mobocertinib succinate
2389149-74-8
C36H45N7O8
CK2/ERK8-IN-1
1085822-09-8
C11H9Br4N3O2
Chrysophanol
1,8-Dihydroxy-3-methylanthrachinon
481-74-3
C15H10O4
JCN037
2305154-31-6
C16H11BrFN3O2
JAK2-IN-6
353512-04-6
C14H10ClN3OS2
(E)-Necrosulfonamide
1360614-48-7
C18H15N5O6S2
APS-2-79
2002381-25-9
C23H21N3O3
NCB-0846
1792999-26-8
C21H21N5O2
GS-444217
1262041-49-5
C23H21N7O
LY3214996
1951483-29-6
C22H27N7O2S
TC13172
2093393-05-4
C17H16N4O5S
AX-15836
2035509-96-5
C32H40N8O5S
Reticuline
(S)-1,2,3,4-Tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methylisochinolin-7-ol
485-19-8
C19H23NO4
AD80
1384071-99-1
C22H19F4N7O
Sorafenib Tosylate
475207-59-1
C21H16ClF3N4O3.C7H8O3S
Sorafenib
284461-73-0
C21H16ClF3N4O3
BRAF inhibitor
918505-61-0
C22H18F2N4O3S
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
Copyright 2019 ? ChemicalBook. All rights reserved